# Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method and Metabolism

> **NCT01527526** · — · COMPLETED · sponsor: **University of Campinas, Brazil** · enrollment: 54 (actual)

## Conditions studied

- Insulin Resistance
- Cardiovascular Disease
- Bone Loss
- Eating Disorders
- Thrombosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01527526
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2015-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527526, "Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method and Metabolism". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01527526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*